The general concept for this study was outlined during a workshop held by the International Life Sciences Institute (ILSI 2000).
The study was outlined in two papers published in Cell last April.
The purpose of the study was outlined to participants.
In that paper, an appendix of 13 main items that should be used to account for the results of a clinical RSA study is outlined.
Initial contact was made by the principal investigator [AB] and/or the Indigenous Research Fellow [RM], the broad objectives of the study were outlined, and an overview of the proposed process of translation was discussed.
Limitations of the study are outlined.
The results of this study are outlined below.
Subsequently, the motivation and contribution of our study is outlined, and the research questions are elaborated.
The methodological structure of the study is outlined in Table 1.
The methodology and the oligonucleotides used in the study are outlined in table 1.
All isolates used in this study are outlined in Table 1.
